Variant report

Variant	esv34610
Chromosome Location	chr9:40910-271132
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:2140)
CpG islands
(count:1771)
Chromatin interactive
region (count:84)
LncRNA
region (count:45)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:2140 , 50 per page) page: 1 2 3 4 5 6 7 ... 43

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:95057-95158	K562	blood:	n/a	n/a
2	ARID3A	chr9:260270-260544	K562	blood:	n/a	n/a
3	ARID3A	chr9:267916-268404	K562	blood:	n/a	n/a
4	ARID3A	chr9:238911-239096	K562	blood:	n/a	n/a
5	ARID3A	chr9:250210-251866	K562	blood:	n/a	n/a
6	ARID3A	chr9:229136-229466	K562	blood:	n/a	n/a
7	ARID3A	chr9:237608-238477	K562	blood:	n/a	n/a
8	ARID3A	chr9:94438-94633	K562	blood:	n/a	chr9:94582-94598
9	ARID3A	chr9:210220-210873	K562	blood:	n/a	n/a
10	ARID3A	chr9:214214-215154	K562	blood:	n/a	n/a
11	ARID3A	chr9:215966-216247	K562	blood:	n/a	n/a
12	ATF1	chr9:211078-211816	K562	blood:	n/a	n/a
13	ATF1	chr9:44552-44676	K562	blood:	n/a	n/a
14	ATF1	chr9:94435-94576	K562	blood:	n/a	n/a
15	ATF1	chr9:222266-222777	K562	blood:	n/a	n/a
16	ATF1	chr9:270753-271026	K562	blood:	n/a	n/a
17	ATF1	chr9:249153-249485	K562	blood:	n/a	n/a
18	ATF3	chr9:210212-210461	K562	blood:	n/a	n/a
19	ATF3	chr9:44488-44733	K562	blood:	n/a	n/a
20	BACH1	chr9:214677-214706	H1-hESC	embryonic stem cell:	n/a	n/a
21	BACH1	chr9:113631-113796	H1-hESC	embryonic stem cell:	n/a	n/a
22	BACH1	chr9:63102-63125	H1-hESC	embryonic stem cell:	n/a	n/a
23	BACH1	chr9:114203-114262	H1-hESC	embryonic stem cell:	n/a	n/a
24	BACH1	chr9:207498-207603	K562	blood:	n/a	n/a
25	BACH1	chr9:214910-215270	H1-hESC	embryonic stem cell:	n/a	n/a
26	BATF	chr9:120835-121041	GM12878	blood:	n/a	n/a
27	BATF	chr9:63198-63553	GM12878	blood:	n/a	chr9:63315-63325
28	BATF	chr9:194727-194900	GM12878	blood:	n/a	n/a
29	BATF	chr9:156921-157465	GM12878	blood:	n/a	n/a
30	BATF	chr9:183522-184128	GM12878	blood:	n/a	n/a
31	BATF	chr9:156635-156839	GM12878	blood:	n/a	n/a
32	BATF	chr9:178036-178376	GM12878	blood:	n/a	n/a
33	BATF	chr9:74615-74984	GM12878	blood:	n/a	n/a
34	BATF	chr9:88665-89067	GM12878	blood:	n/a	chr9:88843-88853 chr9:88842-88853
35	BATF	chr9:177184-177383	GM12878	blood:	n/a	n/a
36	BATF	chr9:185844-186146	GM12878	blood:	n/a	n/a
37	BATF	chr9:116510-116717	GM12878	blood:	n/a	n/a
38	BATF	chr9:88649-88891	GM12878	blood:	n/a	chr9:88843-88853 chr9:88842-88853
39	BATF	chr9:178645-179348	GM12878	blood:	n/a	chr9:179069-179082
40	BATF	chr9:122820-123095	GM12878	blood:	n/a	n/a
41	BATF	chr9:185826-186168	GM12878	blood:	n/a	n/a
42	BATF	chr9:198812-199262	GM12878	blood:	n/a	chr9:198886-198895
43	BATF	chr9:156926-157447	GM12878	blood:	n/a	n/a
44	BATF	chr9:199669-200113	GM12878	blood:	n/a	n/a
45	BATF	chr9:167629-168111	GM12878	blood:	n/a	n/a
46	BATF	chr9:63237-63452	GM12878	blood:	n/a	chr9:63315-63325
47	BATF	chr9:152906-153110	GM12878	blood:	n/a	chr9:152982-152993
48	BATF	chr9:184216-185020	GM12878	blood:	n/a	chr9:184501-184509
49	BATF	chr9:184237-185449	GM12878	blood:	n/a	chr9:184501-184509
50	BATF	chr9:160145-160379	GM12878	blood:	n/a	n/a

(count:1771 , 50 per page) page: 1 2 3 4 5 6 7 ... 36

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:72961-73011	NB4	blood:	n/a
2	chr9:114359-114409	HPAEpiC	pulmonary alveolar:	n/a
3	chr9:72961-73011	NB4	blood:	n/a
4	chr9:114359-114409	HPAEpiC	pulmonary alveolar:	n/a
5	chr9:114140-114190	HCF	heart:	n/a
6	chr9:114140-114190	AG04449	skin:	fetal
7	chr9:214612-214662	IMR90	lung:	fetal
8	chr9:118530-118580	HRE	kidney:	n/a
9	chr9:214268-214318	BE2_C	brain:	n/a
10	chr9:118530-118580	HUVEC	blood vessel:	n/a
11	chr9:114140-114190	SAEC	small airway:	n/a
12	chr9:114140-114190	T-47D	breast:	n/a
13	chr9:213650-213700	HPAEpiC	pulmonary alveolar:	n/a
14	chr9:214690-214740	AG09319	gingival:	n/a
15	chr9:118091-118141	GM12878	blood:	n/a
16	chr9:117044-117094	H1-hESC	embryonic stem cell:	embryo
17	chr9:117044-117094	A549	lung:	n/a
18	chr9:117608-117658	GM12891	blood:	n/a
19	chr9:214690-214740	A549	lung:	n/a
20	chr9:117608-117658	HNPCEpiC	eye:	n/a
21	chr9:73568-73618	HEEpiC	esophagus:	n/a
22	chr9:72961-73011	GM06990	blood:	n/a
23	chr9:109039-109089	GM12891	blood:	n/a
24	chr9:117044-117094	HNPCEpiC	eye:	n/a
25	chr9:113530-113580	HMEC	breast:	n/a
26	chr9:215368-215418	Caco-2	colon:	n/a
27	chr9:73835-73885	LNCaP	prostate:	n/a
28	chr9:118698-118748	A549	lung:	n/a
29	chr9:211689-211739	Jurkat	blood:	n/a
30	chr9:213650-213700	GM06990	blood:	n/a
31	chr9:215561-215611	PrEC	prostate:	n/a
32	chr9:114140-114190	SK-N-SH	brain:	n/a
33	chr9:214268-214318	HMEC	breast:	n/a
34	chr9:109039-109089	SK-N-MC	brain:	n/a
35	chr9:214690-214740	PrEC	prostate:	n/a
36	chr9:215368-215418	HRPEpiC	eye:	n/a
37	chr9:211689-211739	GM12892	blood:	n/a
38	chr9:168828-168878	NH-A	brain:	n/a
39	chr9:118530-118580	NHBE	bronchial:	n/a
40	chr9:104568-104618	Caco-2	colon:	n/a
41	chr9:118698-118748	HEEpiC	esophagus:	n/a
42	chr9:214268-214318	GM19239	blood:	n/a
43	chr9:114434-114484	HRPEpiC	eye:	n/a
44	chr9:104568-104618	AG10803	skin:	n/a
45	chr9:176893-176943	ovcar-3	ovarian:	n/a
46	chr9:215561-215611	HMEC	breast:	n/a
47	chr9:114838-114888	SKMC	muscle:	n/a
48	chr9:214268-214318	K562	blood:	n/a
49	chr9:104568-104618	PANC-1	pancreas:	n/a
50	chr9:104568-104618	GM12891	blood:	n/a

(count:84 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr9:211790..213319-chr9:241598..244495,2	K562	blood:
2	chr9:213589..216422-chr9:270983..274599,7	K562	blood:
3	chr9:213589..216422-chr9:270983..274599,7	K562	blood:
4	chr9:214044..216353-chr9:222371..224502,2	MCF-7	breast:
5	chr9:246731..252463-chr9:270869..275661,7	K562	blood:
6	chr9:239328..240900-chr9:247584..249872,2	K562	blood:
7	chr9:261493..264345-chr9:269680..272564,2	MCF-7	breast:
8	chr9:211912..213756-chr9:227781..229604,2	K562	blood:
9	chr9:246962..249799-chr9:250077..252857,2	K562	blood:
10	chr9:207715..211592-chr9:270281..275557,5	K562	blood:
11	chr9:224695..226653-chr9:227779..229816,2	K562	blood:
12	chr9:270180..272736-chr9:272837..274435,2	K562	blood:
13	chr9:214856..218562-chr9:240584..242539,3	K562	blood:
14	chr9:226722..229215-chr9:247840..250679,2	K562	blood:
15	chr9:223853..225771-chr9:261619..263535,2	K562	blood:
16	chr9:235818..237375-chr9:247234..248835,2	K562	blood:
17	chr9:212545..218648-chr9:270340..281940,20	K562	blood:
18	chr9:262046..270232-chr9:270847..276392,11	K562	blood:
19	chr9:261493..264345-chr9:269680..272564,2	MCF-7	breast:
20	chr9:264854..268401-chr9:271602..276392,5	K562	blood:
21	chr9:247322..249745-chr9:277912..279940,2	K562	blood:
22	chr9:207956..209819-chr9:211466..213662,2	MCF-7	breast:
23	chr9:210056..211721-chr9:271493..274380,2	K562	blood:
24	chr9:246962..249799-chr9:250077..252857,2	K562	blood:
25	chr9:224171..226015-chr9:253370..255238,2	MCF-7	breast:
26	chr9:244363..245872-chr9:248878..250809,2	K562	blood:
27	chr9:223210..226112-chr9:277917..282090,3	K562	blood:
28	chr9:258428..261727-chr9:265742..268870,3	K562	blood:
29	chr9:213410..215081-chr9:270583..272682,2	MCF-7	breast:
30	chr9:255761..258409-chr9:263285..266102,2	K562	blood:
31	chr9:207871..210695-chr9:212521..216858,5	MCF-7	breast:
32	chr9:213603..216956-chr9:218226..220394,3	K562	blood:
33	chr9:207956..209819-chr9:211466..213662,2	MCF-7	breast:
34	chr9:214778..216543-chr9:219574..221163,2	MCF-7	breast:
35	chr20:61557637..61559255-chr9:214332..216174,2	MCF-7	breast:
36	chr9:212545..218648-chr9:270340..281940,20	K562	blood:
37	chr9:212468..215901-chr9:260350..263868,4	K562	blood:
38	chr9:226722..229215-chr9:247840..250679,2	K562	blood:
39	chr9:265556..268525-chr9:268878..270498,2	K562	blood:
40	chr9:237104..239333-chr9:240417..242425,2	K562	blood:
41	chr9:237104..239333-chr9:240417..242425,2	K562	blood:
42	chr9:218197..221460-chr9:224650..228237,4	K562	blood:
43	chr9:224695..226653-chr9:227779..229816,2	K562	blood:
44	chr9:224171..226015-chr9:253370..255238,2	MCF-7	breast:
45	chr9:227507..229537-chr9:238867..240547,2	K562	blood:
46	chr9:216842..219174-chr9:220888..224256,4	K562	blood:
47	chr9:239328..240900-chr9:247584..249872,2	K562	blood:
48	chr9:237820..240828-chr9:247584..251042,3	K562	blood:
49	chr9:237820..240828-chr9:247584..251042,3	K562	blood:
50	chr9:218197..221460-chr9:224650..228237,4	K562	blood:

(count:45 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FOXD4-2	chr9:101014-101304	NONHSAT129895
2	lnc-DOCK8-3	chr9:74149-74205	ENSG00000225655.1
3	lnc-DOCK8-6	chr9:69345-69537	NONHSAT129886
4	lnc-C9orf66-1	chr9:267966-268273	ENSG00000235880.1
5	lnc-DOCK8-6	chr9:64882-65298	NONHSAT129888
6	lnc-DOCK8-3	chr9:74882-75298	ENSG00000225655.1
7	lnc-FOXD4-4	chr9:91002-91304	NONHSAT129893
8	lnc-DOCK8-3	chr9:72716-72816	ENSG00000225655.1
9	lnc-FOXD4-4	chr9:92473-92541	ucscGeneNc_uc003zfy_2
10	lnc-FOXD4-2	chr9:103694-103754	NONHSAT129896
11	lnc-FOXD4-4	chr9:90804-91304	NONHSAT129892
12	lnc-DOCK8-6	chr9:64882-65292	ucscGeneNc_uc003zfx_2
13	lnc-FOXD4-4	chr9:92740-92941	NONHSAT129893
14	lnc-FOXD4-4	chr9:92740-92941	ucscGeneNc_uc003zfy_2
15	lnc-DOCK8-3	chr9:72706-72816	ENSG00000225655.1
16	lnc-FOXD4-3	chr9:114040-115772	NONHSAT129899
17	lnc-DOCK8-6	chr9:62701-62816	NONHSAT129886
18	lnc-FOXD4-4	chr9:92740-92850	NONHSAT129892
19	lnc-FOXD4-5	chr9:151745-152078	NONHSAT129910
20	lnc-FOXD4-2	chr9:108804-109469	NONHSAT129897
21	lnc-FOXD4-2	chr9:102716-103067	NONHSAT129896
22	lnc-FOXD4-1	chr9:112716-113067	ENSG00000231808
23	lnc-DOCK8-3	chr9:74882-75298	ENSG00000225655.1
24	lnc-DOCK8-6	chr9:62716-62816	NONHSAT129888
25	lnc-DOCK8-3	chr9:79345-79537	ENSG00000225655.1
26	lnc-FOXD4-1	chr9:113694-113754	ENSG00000231808
27	lnc-FOXD4-4	chr9:90995-91304	ucscGeneNc_uc003zfy_2
28	lnc-FOXD4-2	chr9:102740-102941	ENSG00000227917
29	lnc-FOXD4-2	chr9:101002-101304	ENSG00000227917
30	lnc-DOCK8-6	chr9:64882-65298	NONHSAT129887
31	lnc-DOCK8-6	chr9:62706-62816	NONHSAT129887
32	lnc-FOXD4-2	chr9:102473-102541	ENSG00000227917
33	lnc-FOXD4-5	chr9:154709-154795	NONHSAT129910
34	lnc-FOXD4-4	chr9:92473-92541	NONHSAT129893
35	lnc-FOXD4-5	chr9:156481-156527	NONHSAT129910
36	lnc-DOCK8-6	chr9:78742-78826	NONHSAT129886
37	lnc-FOXD4-2	chr9:109316-109471	NONHSAT129895
38	lnc-DOCK8-3	chr9:72701-72816	ENSG00000225655.1
39	lnc-DOCK8-6	chr9:62698-62816	ucscGeneNc_uc003zfx_2
40	lnc-FOXD4-2	chr9:109596-109842	NONHSAT129897
41	lnc-FOXD4-3	chr9:113606-113656	NONHSAT129899
42	lnc-FOXD4-2	chr9:102740-102850	NONHSAT129895
43	lnc-DOCK8-3	chr9:88742-88826	ENSG00000225655.1
44	lnc-FOXD4-5	chr9:161567-161647	NONHSAT129910
45	lnc-DOCK8-6	chr9:64149-64205	NONHSAT129888

No data

Variant related genes	Relation type
DOCK8	TF binding region
ENSG00000231808	TF binding region
ENSG00000225655	TF binding region
FOXD4	TF binding region
ENSG00000144140	TF binding region
ENSG00000227917	TF binding region
CBWD1	TF binding region
C9orf66	TF binding region
DOCK8	CpG island
ENSG00000231808	CpG island
ENSG00000225655	CpG island
FOXD4	CpG island
ENSG00000144140	CpG island
ENSG00000227917	CpG island
CBWD1	CpG island
C9orf66	CpG island
ENSG00000107099	chromatin interactions
ENSG00000183784	chromatin interactions
ENSG00000235880	chromatin interactions
ENSG00000101191	chromatin interactions

Extended variants
information (count: 7690 )
Associated
traits (count: 119 )

Variant overlapped rSNPs/rCNVs (count:7690 , 50 per page) page: 1 2 3 4 5 6 7 ... 154

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs75838906	chr9:40910-40911	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs539109487	chr9:40912-40913	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs554291253	chr9:40913-40914	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs201538667	chr9:40961-40962	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs572498478	chr9:40965-40966	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs543037707	chr9:40978-40979	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs561274126	chr9:40980-40981	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs3877475	chr9:40997-40998	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs4514109	chr9:41044-41045	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs543606226	chr9:41054-41055	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs564902196	chr9:41068-41069	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs532092261	chr9:41097-41098	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs147964983	chr9:41099-41100	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs112691055	chr9:41114-41115	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs78824042	chr9:41160-41161	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs529689551	chr9:41164-41165	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs547867685	chr9:41174-41175	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs200701368	chr9:41179-41180	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs567960787	chr9:41195-41196	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs147670141	chr9:41206-41207	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs201672827	chr9:41208-41209	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs2811009	chr9:41231-41232	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs550373982	chr9:41253-41254	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs200047968	chr9:41262-41263	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs189069232	chr9:41266-41267	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs539211309	chr9:41267-41268	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs554350818	chr9:41271-41272	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs182459073	chr9:41274-41275	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs536659121	chr9:41275-41276	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs187360714	chr9:41286-41287	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs370178367	chr9:41300-41301	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs576306382	chr9:41306-41307	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs192206259	chr9:41316-41317	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs183041286	chr9:41319-41320	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs2998939	chr9:41340-41341	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs112894984	chr9:41378-41379	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs201384934	chr9:41399-41400	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs185822786	chr9:41400-41401	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs540824095	chr9:41419-41420	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs562745381	chr9:41422-41423	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs531510885	chr9:41436-41437	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs116717151	chr9:41440-41441	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs190129145	chr9:41466-41467	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs182366528	chr9:41467-41468	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs550233075	chr9:41471-41472	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs571965315	chr9:41493-41494	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs187951291	chr9:41496-41497	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs547968239	chr9:41503-41504	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs566181172	chr9:41516-41517	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs374807031	chr9:41579-41580	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:119)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	20164920	CNVD
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Lynch syndrome	18415027	CNVD
Retinoblastoma	21504564	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	22286061	CNVD
Williams-beuren syndrome	18553513	CNVD
Disorders of sex development	21048976	CNVD
Pilocytic astrocytoma	18622384	CNVD
Pilomyxoid astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
prenatal diagnosis	20453657	CNVD
Gastric cancer	16715143	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Autism	22495311	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
early-passage human iPS cells	21368824	CNVD
Schizophrenia	20967226	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Schizophrenia	23813976	CNVD
Lung cancer	18438408	CNVD
Autism	20531469	CNVD
Intracranial ependymoma	16609018	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Developmental delay	20808231	CNVD
Obesity	20808231	CNVD
Myelodysplastic syndrome	21251322	CNVD
Primary immunodeficiency	22942019	CNVD
Melanoma	20877625	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	21215367	CNVD
Renal cell carcinoma	21215367	CNVD
Williams Syndrome	20824207	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Pancreatic cancer	17952125	CNVD
T-cell lymphomas	22341440	CNVD

Chromatin state (count:2013 , 50 per page) page: 1 2 3 4 5 6 7 ... 41

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:40200-41200	Weak transcription	K562	blood
2	chr9:40800-41200	Enhancers	Monocytes-CD14+_RO01746	blood
3	chr9:41000-42000	Enhancers	Primary monocytes fromperipheralblood	blood
4	chr9:41000-42000	Enhancers	Primary neutrophils fromperipheralblood	blood
5	chr9:41200-41600	Enhancers	K562	blood
6	chr9:41200-41600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
7	chr9:41600-42400	Enhancers	Monocytes-CD14+_RO01746	blood
8	chr9:41600-43800	Weak transcription	K562	blood
9	chr9:42400-43800	Weak transcription	Monocytes-CD14+_RO01746	blood
10	chr9:43800-44000	Enhancers	Primary monocytes fromperipheralblood	blood
11	chr9:43800-44800	Enhancers	K562	blood
12	chr9:44000-44200	Enhancers	Monocytes-CD14+_RO01746	blood
13	chr9:44800-46200	Weak transcription	K562	blood
14	chr9:46200-47600	Enhancers	K562	blood
15	chr9:46400-46600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
16	chr9:48400-52400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
17	chr9:52400-53400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr9:52600-53000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
19	chr9:62000-62200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
20	chr9:62200-63000	Enhancers	Fetal Thymus	thymus
21	chr9:62800-63000	Enhancers	Dnd41	blood
22	chr9:63000-63200	Enhancers	Primary T helper cells PMA-I stimulated	--
23	chr9:63000-63200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
24	chr9:63000-63200	Flanking Active TSS	Fetal Thymus	thymus
25	chr9:63000-63200	Flanking Active TSS	Dnd41	blood
26	chr9:63000-63400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
27	chr9:63000-63400	Enhancers	Primary monocytes fromperipheralblood	blood
28	chr9:63000-63400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
29	chr9:63000-63600	Enhancers	Primary T cells fromperipheralblood	blood
30	chr9:63000-63600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
31	chr9:63000-63600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
32	chr9:63000-63600	Enhancers	Fetal Lung	lung
33	chr9:63000-64000	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
34	chr9:63000-64200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
35	chr9:63200-63400	Enhancers	Primary hematopoietic stem cells short term culture	blood
36	chr9:63200-63400	Active TSS	Fetal Thymus	thymus
37	chr9:63200-64000	Active TSS	Dnd41	blood
38	chr9:63600-65800	Weak transcription	Fetal Lung	lung
39	chr9:64000-64200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
40	chr9:64000-64200	Flanking Active TSS	Dnd41	blood
41	chr9:64200-64800	Enhancers	Dnd41	blood
42	chr9:65800-66000	Enhancers	Fetal Lung	lung
43	chr9:72200-74000	Active TSS	NHLF	lung
44	chr9:72600-73000	Bivalent/Poised TSS	Fetal Muscle Trunk	muscle
45	chr9:72800-73000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
46	chr9:72800-73000	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
47	chr9:72800-73000	Enhancers	Primary hematopoietic stem cells	blood
48	chr9:72800-73000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
49	chr9:72800-73000	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
50	chr9:72800-73000	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links